Medical Disclaimer

This is the part you should read before you read anything else on this site. The editorial coverage here is researched, hedged, and written carefully — but it is not medical advice and it is not a substitute for a licensed-physician consultation. The disclosures below set out what the site is, what it cannot be, and the limits a careful reader should hold the writing inside.

Not medical advice

The articles, guides, glossary entries, and news pieces on gangnam-ultherapy-prime.com are editorial — written for readers researching Ultherapy, Ultherapy Prime, and adjacent skin-tightening treatments — and do not constitute medical advice, a medical diagnosis, a prescription, or a recommendation that any specific procedure is appropriate for any specific reader. I describe mechanisms, indications, recovery envelopes, and the published clinical literature in the language the literature uses; I describe my own recovery from my own treatments in the first person and label it as personal experience. Neither category is a substitute for the in-person clinical consultation in which a licensed physician reviews your medical history, examines your face and skin, discusses contraindications, and decides whether you are a candidate.

Candidacy varies — yours is not mine

Ultherapy and Ultherapy Prime candidacy varies significantly between individuals, and the realistic outcome envelope depends on factors a published article cannot evaluate — age, skin laxity, underlying bone structure, prior treatments, current medications, autoimmune history, pregnancy or breastfeeding status, and the specific indication you are treating. My recovery on my fourth Seoul trip is not your recovery. The before-and-after photos in published clinical studies are sample-size-limited and do not represent the full distribution of patient outcomes. "Patients report" and "may help" hedging language appears throughout the editorial coverage on purpose: those phrases are doing real work. They mean the published literature supports the claim with caveats, not that the claim applies uniformly.

Consult a licensed physician

If you are considering Ultherapy, Ultherapy Prime, or any of the adjacent procedures discussed on this site, the editorial coverage is — at best — the orientation a careful reader brings to a consultation with a licensed physician. The consultation is the appropriate place to discuss your candidacy, your contraindications, the realistic outcome envelope for your face, the medications and lifestyle adjustments warranted in advance of treatment, and the specific protocol your treating physician recommends. For an in-Korea consultation that means a licensed Korean specialist; for the pre-travel review that means your home-country physician — your dermatologist, your plastic surgeon, your primary-care doctor, depending on what you are bringing into the conversation. Reading this site does not create a doctor-patient relationship between you and me, between you and HEIM GLOBAL, or between you and any clinic the site mentions. The relationship begins at the consultation, not at the article.

FDA/KFDA-cleared device disclosure

Ultherapy and Ultherapy Prime are micro-focused ultrasound (MFU or MFU-V) devices manufactured by Merz Aesthetics. The original Ultherapy device received U.S. Food and Drug Administration (FDA) clearance for non-invasive lifting of the brow, submental tissue, and neck, and for improvement of lines and wrinkles on the décolletage; it is also cleared by the Korean Ministry of Food and Drug Safety (KFDA / MFDS) for use in Korea. Ultherapy Prime is the platform's second-generation update; clearance status varies by region and indication, and the device is in active clinical use in Korea under KFDA classification. Where this site references FDA-cleared or KFDA-cleared indications I cite the underlying clearance database or manufacturer documentation. "Cleared" is a regulatory term that means the device may legally be marketed for the named indication; it is not a clinical claim that the device works for every candidate, that results are guaranteed, or that the published indications cover every face. Off-label use, where it is discussed on this site, is labeled as such.

Published study sample-size limits

The peer-reviewed literature on Ultherapy and Ultherapy Prime is meaningful but limited. The pivotal clearance studies and the secondary literature typically enroll patient cohorts in the dozens to low hundreds, follow them for three to twelve months, and report outcomes using a mix of physician-graded and patient-reported scales. The studies are useful for establishing that the device produces a measurable lifting effect in the studied population — which is what "FDA-cleared" rests on — but they are not powered to predict whether you, individually, will fall into the responder population, the partial-responder population, or the non-responder population. When this site cites a study I name the journal, the year, and the patient cohort size in plain text so a careful reader can check the reasoning. Where a claim is widely held but not yet supported by adequately powered literature, the writing says so. The hedging is not for legal cover. It is for accuracy.

“Last updated: 2026-05-09. Reading this site does not create a doctor-patient relationship.”

Editorial desk, gangnam-ultherapy-prime.com

Frequently asked questions

Does reading this site or contacting the WhatsApp coordinator create a doctor-patient relationship?

No. Reading the editorial coverage, sending an email to the editorial address, or sending a WhatsApp message to the HEIM GLOBAL coordinator does not create a doctor-patient relationship between you and me, between you and HEIM GLOBAL, or between you and any clinic the site mentions. The doctor-patient relationship begins at an in-person clinical consultation with a licensed physician.

If a piece on this site says a patient outcome is typical, does that mean I'll get the same result?

No. "Typical" in the editorial coverage refers to the published literature's reporting of average or median outcomes in studied cohorts. Your face is not the cohort. Your skin laxity, age, underlying bone structure, prior treatments, and dozens of other variables affect your individual response. The realistic envelope for you is something your treating physician determines at the consultation, not something a published article can predict.